• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDX-1、CDX-2、TTF-1 和 CK7:用于胰腺神经内分泌肿瘤的可靠免疫组化标志物。

PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.

机构信息

Department of Pathology, University of Washington School of Medicine, Seattle, 98195-6100, USA.

出版信息

Am J Surg Pathol. 2012 May;36(5):737-43. doi: 10.1097/PAS.0b013e31824aba59.

DOI:10.1097/PAS.0b013e31824aba59
PMID:22498824
Abstract

Neuroendocrine tumors (NETs) occur in virtually all sites of the body. As NETs arising in different organs share similar morphologic features, distinguishing metastatic from primary NETs on the basis of morphologic grounds alone is difficult. Pancreatic duodenal homeobox 1 (PDX-1) is a Hox-type transcription factor that is essential for both exocrine and endocrine pancreatic differentiation and maintenance of β-cell function. We investigated PDX-1 as an immunohistochemical (IHC) marker in primary pancreatic NETs. Eighty primary NETs [25 pancreatic, 29 bronchopulmonary, and 26 in the gastrointestinal (GI) tract] and 13 metastatic NETs in the liver were studied. Clinical and radiologic data were reviewed to confirm the stated primary sites. IHC analysis for PDX-1, CDX-2, thyroid transcription factor-1 (TTF-1), keratin 7 (CK7), and keratin 20 (CK20) was performed, and the results were based on review blinded to the primary sites. PDX-1 was seen in 18 of 25 (72%) pancreatic NETs; in contrast, only 3 of 29 (10%) bronchopulmonary NETs and 1 of 26 (4%) GI NETs were positive. PDX-1 was therefore 93% specific and 72% sensitive for pancreatic NETs. TTF-1 was expressed only in bronchopulmonary NETs; all other NETs were negative for TTF-1. CK7 was also very specific (92%) and moderately sensitive (66%) for bronchopulmonary NETs. CDX-2 was seen in 22 of 26 (85%) cases of GI NETs and in only 1 of 51 (2%) cases of extra-GI NETs. Thus, CDX-2 was 98% specific and 85% sensitive for GI NETs. In terms of metastatic NETs found in the liver, PDX-1 was positive in 5 of 5 cases of metastatic pancreatic NETs and 2 of 2 cases of metastatic duodenal NETs. PDX-1 is highly specific, with very good overall diagnostic accuracy for pancreatic NETs. An IHC panel including PDX-1, CDX-2, TTF-1, CK7, and CK20 may be useful in distinguishing NETs of pancreatic origin from other primaries.

摘要

神经内分泌肿瘤(NETs)几乎可发生于全身所有部位。由于不同器官起源的 NETs 具有相似的形态学特征,仅基于形态学基础来区分转移性和原发性 NETs 较为困难。胰腺十二指肠同源盒 1(PDX-1)是一种 Hox 型转录因子,对于外分泌和内分泌胰腺的分化以及β细胞功能的维持都是必需的。我们研究了 PDX-1 作为原发性胰腺 NETs 的免疫组织化学(IHC)标志物。研究了 80 例原发性 NETs[25 例胰腺、29 例支气管肺和 26 例胃肠道(GI)]和 13 例肝转移 NETs。回顾临床和影像学数据以确认所陈述的原发部位。进行了 PDX-1、CDX-2、甲状腺转录因子-1(TTF-1)、角蛋白 7(CK7)和角蛋白 20(CK20)的免疫组化分析,结果基于对原发部位不知情的回顾性审查。PDX-1 在 25 例胰腺 NETs 中的 18 例中呈阳性;相比之下,仅在 29 例支气管肺 NETs 中的 3 例和 26 例 GI NETs 中的 1 例呈阳性。因此,PDX-1 对胰腺 NETs 的特异性为 93%,敏感性为 72%。TTF-1 仅在支气管肺 NETs 中表达;所有其他 NETs 均为 TTF-1 阴性。CK7 对支气管肺 NETs 也具有非常高的特异性(92%)和中等敏感性(66%)。CDX-2 在 26 例 GI NETs 中的 22 例中可见,而在 51 例非 GI NETs 中的 1 例中可见。因此,CDX-2 对 GI NETs 的特异性为 98%,敏感性为 85%。就肝转移 NETs 而言,PDX-1 在 5 例转移性胰腺 NETs 和 2 例转移性十二指肠 NETs 中均为阳性。PDX-1 具有高度特异性,对胰腺 NETs 的总体诊断准确性非常高。包括 PDX-1、CDX-2、TTF-1、CK7 和 CK20 的 IHC 组合可能有助于区分胰腺起源的 NETs 与其他原发性肿瘤。

相似文献

1
PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.PDX-1、CDX-2、TTF-1 和 CK7:用于胰腺神经内分泌肿瘤的可靠免疫组化标志物。
Am J Surg Pathol. 2012 May;36(5):737-43. doi: 10.1097/PAS.0b013e31824aba59.
2
Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.对CDX-2、PDX-1、NESP-55和TTF-1进行免疫组织化学染色有助于鉴别胃肠道类癌肿瘤与胰腺内分泌肿瘤和肺类癌肿瘤。
Am J Surg Pathol. 2009 Apr;33(4):626-32. doi: 10.1097/PAS.0b013e31818d7d8b.
3
Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.CDX-2和TTF-1表达在鉴别不明原发灶转移性神经内分泌肿瘤中的诊断价值
Appl Immunohistochem Mol Morphol. 2007 Dec;15(4):407-14. doi: 10.1097/01.pai.0000210416.53493.0f.
4
Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung.胰腺、卵巢和肺黏液性囊性肿瘤独特的免疫组化特征。
Histol Histopathol. 2009 Jan;24(1):77-82. doi: 10.14670/HH-24.77.
5
Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.原发性卵巢类癌肿瘤可能表达尾型同源盒转录因子2(CDX-2):这是在鉴别卵巢转移性肠类癌肿瘤时的一个潜在陷阱。
Int J Gynecol Pathol. 2009 Jan;28(1):41-8. doi: 10.1097/PGP.0b013e31817a8f51.
6
Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.细胞角蛋白7和20以及甲状腺转录因子1有助于区分肺类癌、胃肠道类癌和胰腺内分泌肿瘤。
Hum Pathol. 2001 Oct;32(10):1087-93. doi: 10.1053/hupa.2001.28245.
7
CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.CDX2、细胞角蛋白7和20在直肠腺癌中的免疫反应性。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):196-201. doi: 10.1097/PAI.0b013e31819268f2.
8
[Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].[转录因子PDX-1表达在胰腺及其他器官神经内分泌肿瘤和非神经内分泌肿瘤中的鉴别诊断价值]
Arkh Patol. 2019;81(5):11-21. doi: 10.17116/patol20198105111.
9
Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.肝转移性高分化神经内分泌肿瘤起源的免疫组化特征
Am J Surg Pathol. 2017 Jul;41(7):915-922. doi: 10.1097/PAS.0000000000000876.
10
Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.甲状腺转录因子-1(TTF-1)、细胞角蛋白20(CK20)和细胞角蛋白7(CK7)免疫组化在原发性和继发性肺腺癌诊断中的作用
Kaohsiung J Med Sci. 2006 Jan;22(1):14-9. doi: 10.1016/S1607-551X(09)70214-1.

引用本文的文献

1
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.台湾胃肠胰神经内分泌肿瘤的临床结局:一项多中心注册研究——TCOG T1214研究
Cancer. 2025 Sep 1;131(17):e70019. doi: 10.1002/cncr.70019.
2
Clinicopathological Perspectives of Liver Mass Biopsies: A Single Center Experience of 406 Cases.肝脏肿块活检的临床病理视角:单中心406例经验
Arch Iran Med. 2025 Jun 1;28(6):347-355. doi: 10.34172/aim.34218.
3
Extended Hormone Profiling Identifies a Wider Network of Duodenal Neuroendocrine Tumor Subtypes.
扩展激素谱分析确定了更广泛的十二指肠神经内分泌肿瘤亚型网络。
Endocr Pathol. 2025 Jun 24;36(1):23. doi: 10.1007/s12022-025-09868-x.
4
Mixed Neuroendocrine-Squamous Cell Carcinoma of the Hand With Metastatic Dissemination: A Case Report.手部混合性神经内分泌-鳞状细胞癌伴转移性播散:一例报告
Eplasty. 2024 Aug 15;24:e45. eCollection 2024.
5
The long non-coding RNA keratin-7 antisense acts as a new tumor suppressor to inhibit tumorigenesis and enhance apoptosis in lung and breast cancers.长链非编码 RNA 角蛋白-7 反义链作为一种新的肿瘤抑制因子,可抑制肺癌和乳腺癌的肿瘤发生并增强细胞凋亡。
Cell Death Dis. 2023 Apr 25;14(4):293. doi: 10.1038/s41419-023-05802-3.
6
Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup.原发灶不明的转移性神经内分泌肿瘤:病理检查的线索
Cancers (Basel). 2022 Apr 28;14(9):2210. doi: 10.3390/cancers14092210.
7
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.《2022 年世卫组织神经内分泌肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16.
8
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.消化系统神经内分泌肿瘤的病理学报告:你一直想知道但又不敢问的一切。
Front Endocrinol (Lausanne). 2021 Apr 23;12:680305. doi: 10.3389/fendo.2021.680305. eCollection 2021.
9
Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation.卵巢癌中多种生物标志物的检测与分析:在诊断、治疗及预后评估中的临床意义
Gland Surg. 2020 Dec;9(6):2175-2186. doi: 10.21037/gs-20-811.
10
Primary hepatic neuroendocrine carcinoma coexisting with distal cholangiocarcinoma: A case report and review of the literature.原发性肝神经内分泌癌合并远端胆管癌:一例报告并文献复习
Medicine (Baltimore). 2020 Jun 26;99(26):e20854. doi: 10.1097/MD.0000000000020854.